S&P 500 Consumer Staples Sector SEC Filings — November 02, 2026

USA S&P 500 Consumer Staples

By Gunpowder Editorial ·

9 high priority 3 medium priority 12 total filings analysed

Executive Summary

The 12 filings reveal a consumer staples sector in transition, with M&A reshaping competitive dynamics and margin pressures offset by selective pricing power. Clorox's Q1 FY2027 sales surged 33.3% YoY to $1,905M, boosted by the GOJO acquisition, but gross margin contracted 130 bps to 40.4% and interest expense jumped 126%, pushing stockholders' equity into a $39M deficit.

Estée Lauder delivered a strong Q1 FY2027 with sales up 6.7% to $3,715M, operating income more than doubling to $408M, and gross margin expanding 230 bps to 75.7%, prompting a raised FY2027 outlook. Kimberly-Clark completed its transformative acquisition of Kenvue on November 2, 2026, creating a consumer health giant with 10 billion-dollar brands and targeting ~$2.1B in run-rate synergies. Insider activity was mixed: Hershey Trust continued selling shares under a 10b5-1 plan, while Kimberly-Clark executives had shares withheld for taxes upon RSU vesting, and Church & Dwight awarded small phantom stock grants. P&G's $352M 50-year floating rate note issuance highlights ongoing debt market access. Overall, the sector shows divergent margin trends, with Estée Lauder outperforming while Clorox faces inflationary headwinds, and M&A integration risks loom large for Kimberly-Clark.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q · Form 4 · 8-K

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from October 30, 2026.

Investment Signals (12)

  • Estée Lauder (BULLISH)
    ▲

    Q1 FY2027 net sales grew 6.7% YoY to $3,715M, operating income more than doubled to $408M (operating margin 11.0% vs 4.9%), and gross margin expanded 230 bps to 75.7%; management raised FY2027 outlook on sales, margin, and EPS

  • ▲

    Completed acquisition of Kenvue on Nov 2, 2026, creating a combined entity with 10 billion-dollar brands and four segments; management reiterates ~$2.1B run-rate synergies (~$1.9B cost synergies over three years plus ~$500M revenue-synergy profit)

  • Clorox ↓ (BULLISH)
    ▲

    Q1 FY2027 net sales surged 33.3% YoY to $1,905M, driven by GOJO acquisition (~15 points) and organic growth of 18%; diluted EPS jumped 114% to $1.39 and adjusted EPS rose 82% to $1.55

  • CEO Richard Dierker awarded 40.334 phantom stock units at $107.23 (~$4.33K), signaling alignment with shareholders; small but consistent insider awards across executives [NEUTRAL/BULLISH]

  • P&G (NEUTRAL)
    ▲

    Closed $352M 50-year floating rate note offering, demonstrating continued access to long-term debt markets at potentially favorable terms

  • Estée Lauder (BULLISH)
    ▲

    Fragrance sales surged 19% (organic +20%) and Skin Care rose 4%, indicating strong demand in higher-margin categories

  • Clorox ↓ (NEUTRAL)
    ▲

    Maintained FY2027 sales and adjusted EPS outlook ranges, though now expects adjusted EPS toward the low end ($5.70-$6.00, +3% to 8%)

  • ▲

    Kenvue acquisition adds four new segments with combined annual sales: North America ~$18.0B, Asia Pacific Focus Markets ~$4.3B, EMEA ~$5.0B, Enterprise Markets ~$4.3B

  • Estée Lauder (BULLISH)
    ▲

    Adjusted EPS rose to $0.72 from $0.32 YoY, and effective tax rate fell to 32.5% from 56.9%, partly due to favorable earnings mix

  • Hershey ↓ (NEUTRAL)
    ▲

    10% owner Hershey Trust sold 5,574 shares at $165.40 (~$922K) under a 10b5-1 plan; while bearish, the sale is part of a pre-scheduled program and may not reflect negative sentiment

  • Clorox ↓ (BULLISH)
    ▲

    Advertising costs rose 14.5% YoY to $190M, indicating investment in brand support to drive future growth

  • ▲

    Three Kenvue directors joined KMB board, bringing integration expertise; however, three directors stepped down, which could signal governance changes

Risk Flags (10)

  • Clorox↓ [HIGH RISK]
    ▼

    Gross margin contracted 130 bps to 40.4% YoY, and FY2027 gross margin guidance lowered to ~41.5% due to higher commodity, manufacturing, and logistics costs; interest expense surged 126% to $52M

  • Clorox↓ [HIGH RISK]
    ▼

    Total stockholders' equity fell to a deficit of $39M from $90M at June 30, 2026, driven by a $139M reduction in retained earnings; this weak balance sheet could limit financial flexibility

  • Estée Lauder [MEDIUM RISK]
    ▼

    Operating cash flow remained negative at -$166M (though improved from -$340M), with accounts receivable swelling $399M and inventory rising $146M; cash declined $300M to $3,198M and total debt remained elevated at $7,251M

  • Kimberly-Clark↓ [HIGH RISK]
    ▼

    Integration risk from Kenvue acquisition is significant; filing flags indebtedness and synergy-realization risks, and combined segment sales are not Regulation S-X compliant pro forma information

  • Hershey↓ [MEDIUM RISK]
    ▼

    10% owner Hershey Trust sold shares in 11 transactions totaling ~$2.2M under a 10b5-1 plan; continued sales could pressure the stock, though the trust still holds 466,119 shares

  • Clorox↓ [MEDIUM RISK]
    ▼

    Selling and administrative expenses rose 4.7% YoY to $290M, and R&D rose 3.6% to $29M, contributing to margin pressure

  • Estée Lauder [MEDIUM RISK]
    ▼

    Makeup grew only 1% and Hair Care declined 1% (flat organically), indicating uneven growth across categories

  • Kimberly-Clark↓ [LOW RISK]
    ▼

    Executive RSU vesting resulted in tax withholding at $107.94 per share (CHRO Panayiotou sold 2,305 shares for $249K; President Carmichael sold 974 shares for $105K); while routine, it adds to share supply

  • P&G [LOW RISK]
    ▼

    Issued $352M in 50-year floating rate notes, adding long-term debt; while routine, it increases interest rate sensitivity

  • Clorox↓ [MEDIUM RISK]
    ▼

    GOJO acquisition purchase consideration of $2,147M contributed to increased leverage and interest expense, with integration costs expected to impact FY2027 results

Opportunities (10)

  • Estée Lauder (OPPORTUNITY)
    ◆

    Raised FY2027 outlook on sales, margin, and EPS; gross margin expansion of 230 bps and operating margin expansion of 610 bps signal strong turnaround; Fragrance organic growth of 20% and Skin Care growth of 4% provide momentum

  • Kimberly-Clark↓ (OPPORTUNITY)
    ◆

    Kenvue acquisition creates a consumer health leader with 10 billion-dollar brands and ~$2.1B run-rate synergies; combined annual sales of ~$31.6B across four segments; potential for re-rating as synergies are realized

  • Clorox↓ (OPPORTUNITY)
    ◆

    Organic sales rose 18% YoY (lapping ERP-related inventory drawdown), and adjusted EPS rose 82% to $1.55; if margin pressures ease, earnings could surprise to the upside

  • Church & Dwight↓ (OPPORTUNITY)
    ◆

    Insider phantom stock awards at $107.23 suggest management confidence; small grants but consistent with alignment; watch for larger insider buying

  • P&G (OPPORTUNITY)
    ◆

    50-year floating rate note issuance at potentially low rates could fund growth initiatives or share buybacks; strong credit rating implied

  • Hershey↓ (OPPORTUNITY)
    ◆

    Insider sales under 10b5-1 plan may create buying opportunities if stock price dips; trust retains 466,119 shares, indicating continued significant ownership

  • Estée Lauder (OPPORTUNITY)
    ◆

    Effective tax rate fell to 32.5% from 56.9%, and adjusted tax rate to 31.9% from 40.5%, boosting net earnings; if sustainable, could enhance EPS growth

  • Clorox↓ (OPPORTUNITY)
    ◆

    Advertising spend increased 14.5% YoY to $190M, which could drive market share gains and future sales growth

  • Kimberly-Clark↓ (OPPORTUNITY)
    ◆

    Kenvue shareholders received $3.50 cash plus 0.14625 KMB shares per share; KVUE ceased trading, eliminating a competitor and potentially improving pricing power

  • Sector-wide (OPPORTUNITY)
    ◆

    Consumer staples companies with strong brands and pricing power (Estée Lauder, P&G) are better positioned to navigate inflationary pressures; focus on names with margin expansion

Sector Themes (6)

  • Divergent Margin Trends
    ◆

    Estée Lauder expanded gross margin by 230 bps YoY, while Clorox contracted 130 bps, highlighting varying pricing power and cost management; companies with premium beauty brands (Estée Lauder) are outperforming household products (Clorox) [IMPLICATION: favor premium beauty over commoditized household]

  • M&A Reshaping Competitive Landscape
    ◆

    Kimberly-Clark's acquisition of Kenvue creates a consumer health giant with ~$31.6B in combined sales and ~$2.1B synergies; Clorox's GOJO acquisition added ~15 points to sales growth; consolidation may lead to scale advantages and market share shifts [IMPLICATION: watch for further M&A in consumer health]

  • Insider Activity Mixed
    ◆

    Hershey Trust sold ~$2.2M under 10b5-1 plan, while Kimberly-Clark executives had shares withheld for taxes upon RSU vesting; Church & Dwight awarded small phantom stock; no significant open-market purchases, suggesting cautious insider sentiment [IMPLICATION: lack of strong insider buying may signal limited near-term upside]

  • Cash Flow Pressure
    ◆

    Estée Lauder reported negative operating cash flow of -$166M (improved from -$340M) due to working capital build; Clorox's equity deficit and rising interest expense highlight balance sheet stress; companies with strong cash generation (P&G) are better positioned [IMPLICATION: monitor cash flow trends for dividend sustainability]

  • Guidance Divergence
    ◆

    Estée Lauder raised FY2027 outlook, while Clorox maintained but expects adjusted EPS toward low end and lowered gross margin guidance; this divergence reflects differing demand environments and cost pressures [IMPLICATION: favor companies with positive guidance revisions]

  • Debt Market Access
    ◆

    P&G issued $352M in 50-year floating rate notes, indicating strong demand for high-quality consumer staples debt; this could provide funding for growth or shareholder returns [IMPLICATION: low borrowing costs may support capital allocation strategies]

Watch List (8)

  • Estée Lauder (WATCH)
    👁

    Raised FY2027 outlook; watch for Q2 FY2027 earnings call (date TBD) to confirm margin expansion and cash flow improvement; negative operating cash flow of -$166M needs to turn positive

  • 👁

    Integration of Kenvue acquisition; watch for synergy realization updates and potential restructuring charges; next earnings call (date TBD) will be first with combined results

  • Clorox↓ (WATCH)
    👁

    FY2027 guidance implies adjusted EPS of $5.70-$6.00 (+3% to 8%); watch for commodity cost trends and GOJO integration progress; gross margin guidance of ~41.5% may be revised

  • Hershey↓ (WATCH)
    👁

    Hershey Trust's 10b5-1 selling plan; monitor for further sales and any change in trust ownership; trust holds 466,119 shares after latest sale

  • P&G (WATCH)
    👁

    50-year floating rate notes due 2076; watch for interest rate fluctuations and potential impact on cost of debt; also monitor for any share buyback announcements

  • 👁

    Phantom stock awards to executives; watch for any open-market insider buying or selling, which would provide stronger signal

  • Sector (WATCH)
    👁

    Consumer staples earnings season continues; watch for updates from other S&P 500 consumer staples companies (e.g., Coca-Cola, PepsiCo, Mondelez) for broader trends

  • 👁

    Board changes with three Kenvue directors joining and three stepping down; watch for strategic shifts under new board composition

Filing Analyses (12)
CLOROX CO /DE/ 10-Q mixed materiality 8/10

02-11-2026

Clorox reported Q1 FY2027 net sales of $1,905M, up 33.3% YoY from $1,429M, driven largely by the acquisition of a consumer brands portfolio (purchase consideration $2,147M). Net earnings attributable to Clorox more than doubled to $170M ($1.39 diluted EPS) from $80M ($0.65), but gross margin contracted to 40.4% from 41.7% and interest expense surged 126% to $52M. The company also swung to a total Clorox stockholders' deficit of $39M from equity of $90M at June 30, 2026.

  • · Gross margin declined to 40.4% in Q1 FY2027 from 41.7% in Q1 FY2026, a 130 bps contraction.
  • · Selling and administrative expenses rose 4.7% YoY to $290M; advertising costs rose 14.5% to $190M; R&D rose 3.6% to $29M.
  • · Total Clorox stockholders' equity fell to a deficit of $39M at 9/30/2026 from $90M at 6/30/2026, driven by a $139M reduction in retained earnings.
  • · Cash and cash equivalents increased to $184M from $143M; notes and loans payable rose to $1,175M from $1,086M.
  • · The acquisition added $2,432M in assets and $282M in liabilities, with $716M goodwill, $487M trademarks, and $569M other intangibles.
  • · Net cash provided by operations improved to $143M from $93M, while capital expenditures were $38M vs $36M.
  • · No treasury stock was purchased in Q1 FY2027 vs $129M in Q1 FY2026.
  • · Deferred income taxes decreased to $21M from $84M YoY.
ESTEE LAUDER COMPANIES INC 10-Q mixed materiality 8/10

02-11-2026

Estée Lauder reported Q1 FY2027 net sales of $3,715M, up 6.7% YoY from $3,481M, with operating income more than doubling to $408M from $169M and net earnings jumping to $233M from $47M (diluted EPS $0.64 vs $0.13). However, gross margin pressure persisted as cost of sales fell only 2.7% while SG&A rose 3.0% to $2,365M, and the company burned $166M in operating cash flow (improved from -$340M) as accounts receivable swelled $399M and inventory rose $146M. Cash declined $300M to $3,198M and total debt remained elevated at $7,251M, while restructuring charges fell to $40M from $89M.

  • · Gross margin improved to 75.7% of net sales from 73.4% YoY
  • · Interest expense declined to $83M from $86M YoY
  • · Effective tax rate rose to 32.5% from 56.9% YoY
  • · Accounts receivable rose $399M in the quarter, a larger build than the $358M prior year
  • · Inventory increased $146M versus a $6M decrease in the prior-year quarter
  • · Accrued restructuring balance fell to $432M from $531M at June 30, 2026
  • · Total debt stands at $7,251M ($503M current + $6,748M long-term)
  • · Depreciation and amortization declined to $191M from $200M
  • · Cash flow from investing used $61M vs $116M prior year; capex $69M vs $96M
  • · No deferred consideration payment in Q1 FY2027 vs $150M paid prior year
HERSHEY CO 4 negative materiality 3/10

02-11-2026

10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 5,574 Common Stock, $1.00 par value at $165.40 (~$922K). 11 transactions reported in total. HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL holds 466,119 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 4,952 Common Stock, $1.00 par value at $160.45 (~$795K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 2,126 Common Stock, $1.00 par value at $161.59 (~$344K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 930 Common Stock, $1.00 par value at $162.35 (~$151K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 1,627 Common Stock, $1.00 par value at $163.44 (~$266K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 300 Common Stock, $1.00 par value at $164.12 (~$49.2K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 65 Common Stock, $1.00 par value at $165.67 (~$10.8K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 75 Common Stock, $1.00 par value at $161.77 (~$12.1K)
  • · 10% owner HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL sold 208 Common Stock, $1.00 par value at $162.13 (~$33.7K)
CLOROX CO /DE/ 8-K mixed materiality 8/10

02-11-2026

Clorox reported Q1 FY2027 net sales up 33% to $1.91 billion, boosted by ~15 points from the GOJO acquisition, while organic sales rose 18% largely on lapping the prior-year ERP-related inventory drawdown. Diluted EPS jumped 114% to $1.39 and adjusted EPS rose 82% to $1.55, but gross margin declined 130 basis points to 40.4% on higher commodity, manufacturing and logistics costs. The company maintained its FY2027 sales and adjusted EPS outlook ranges but now expects adjusted EPS toward the low end ($5.70-$6.00, +3% to 8%) and lowered gross margin guidance to ~41.5% amid higher inflationary headwinds.

  • · FY2027 gross margin guidance lowered to about 41.5%, including ~20 basis points of negative impact from GOJO inventory step-up
  • · FY2027 selling and administrative expenses now expected at about 15.5% of net sales, including ~40 basis points of GOJO transaction-related costs
  • · FY2027 advertising and sales promotion spending expected at about 10% of net sales (~12% for retail businesses)
  • · FY2027 effective tax rate expected at about 23%
  • · FY2027 diluted EPS outlook of $5.41-$5.71 includes about 29 cents of GOJO transaction-related costs
  • · FY2026 diluted EPS was $4.81 and adjusted EPS was $5.53; FY2025 diluted EPS was $6.52 and adjusted EPS was $7.72
  • · ERP transition added ~3.5 points of sales and ~90 cents of EPS to FY2025, and the drawdown reduced FY2026 EPS by ~90 cents
  • · GOJO acquisition contributed ~39 points to Health and Wellness segment net sales growth
  • · Household segment adjusted EBIT growth of 11% was the weakest segment performance, held back by higher commodity and manufacturing/logistics costs
  • · International organic sales grew 9% on 9 points of organic volume growth, led by Latin America
PROCTER & GAMBLE Co 8-K neutral materiality 3/10

02-11-2026

Procter & Gamble closed an underwritten public offering of $352,231,000 aggregate principal amount of Floating Rate Notes due November 2, 2076 on November 2, 2026, under its Form S-3 registration statement (No. 333-299472). The 8-K is a routine debt-issuance disclosure with legal opinions and consents filed as exhibits; no operating or financial performance data was provided.

  • · Notes mature November 2, 2076 — a 50-year floating rate instrument
  • · Offering made under Registration Statement on Form S-3 (Registration No. 333-299472)
  • · Exhibits filed: (5)(a) opinion of Travonte Warren, Esq.; (5)(b) opinion of Fried, Frank, Harris, Shriver & Jacobson LLP; (23)(a) and (23)(b) consents; (104) Inline XBRL cover page
  • · Filing signed by Aaron Shepherd, Assistant Secretary, dated November 2, 2026
  • · Company lists 18 series of registered notes across USD, EUR and GBP on the NYSE alongside common stock (PG)
KIMBERLY CLARK CORP 4 neutral materiality 5/10

02-11-2026

Chief Human Resources Officer Panayiotou Stacey J. had withheld for taxes 2,305 Common Stock at $107.94 (~$249K). Panayiotou Stacey J. holds 3,552 shares after the transaction.

  • · Chief Human Resources Officer Panayiotou Stacey J. exercised/converted 5,857 Common Stock
  • · Chief Human Resources Officer Panayiotou Stacey J. had withheld for taxes 2,305 Common Stock at $107.94 (~$249K)
  • · Chief Human Resources Officer Panayiotou Stacey J. exercised/converted 5,857 Restricted Share Units 10/31/2025(w/dividends reinvested)
KIMBERLY CLARK CORP 4 neutral materiality 5/10

02-11-2026

President, North America Carmichael John Patrick had withheld for taxes 974 Common Stock at $107.94 (~$105K). Carmichael John Patrick holds 1,222 shares after the transaction.

  • · President, North America Carmichael John Patrick exercised/converted 2,196 Common Stock
  • · President, North America Carmichael John Patrick had withheld for taxes 974 Common Stock at $107.94 (~$105K)
  • · President, North America Carmichael John Patrick exercised/converted 2,196 Restricted Share Units 10/31/2025 (2-year)
ESTEE LAUDER COMPANIES INC 8-K mixed materiality 8/10

02-11-2026

The Estée Lauder Companies reported fiscal 2027 first quarter net sales of $3,715 million, up 7% year-over-year (organic +6%), with gross margin expanding 230 basis points to 75.7% and operating income more than doubling to $408 million (operating margin 11.0% vs 4.9%). Diluted EPS rose to $0.64 from $0.13 and adjusted EPS to $0.72 from $0.32, prompting the company to raise its full-year fiscal 2027 outlook on sales, margin and EPS. However, growth was uneven: Fragrance surged 19% (organic +20%) and Skin Care rose 4%, while Makeup grew only 1% and Hair Care declined 1% (flat organically), and free cash flow remained negative at $235 million despite improving from negative $436 million.

  • · Gross margin expanded 230 bps to 75.7% from 73.4%; adjusted gross margin expanded 240 bps to 75.7% from 73.3%
  • · Operating margin expanded 610 bps to 11.0% from 4.9%; adjusted operating margin expanded 480 bps to 12.1% from 7.3%
  • · Effective tax rate fell to 32.5% from 56.9% (adjusted 31.9% from 40.5%), partly due to lower prior-year pre-tax income and favorable full-year earnings mix
  • · Free cash flow improved to negative $235 million from negative $436 million; net cash used in operations fell to $166 million from $340 million
  • · Capital expenditures decreased to $69 million from $96 million; dividend payments were $126 million
  • · Hair Care was the only declining category, with net sales of $128 million vs $129 million (-1% reported, flat organic)
  • · Makeup operating results swung to $3 million income from a $15 million loss; Estée Lauder brand makeup sales declined on lower face subcategory sales and launch timing
  • · Prestige beauty share gains in Mainland China, Japan, Korea, U.S. and Western Europe
  • · Completed acquisition of remaining equity interest in Mountain Valley Springs India Private Limited (Forest Essentials) in October 2026
  • · Opened Hainan Fulfillment Center in July 2026; signed second green Virtual Power Purchase Agreement for onshore wind in Spain in August 2026
  • · Company to webcast Capital Markets Experience presentations from Shanghai on November 4, 2026
KIMBERLY CLARK CORP 8-K positive materiality 9/10

02-11-2026

Kimberly-Clark completed its acquisition of Kenvue on November 2, 2026, creating a combined consumer health and wellness leader with 10 billion-dollar brands and four new segments (North America ~$18.0B, Asia Pacific Focus Markets ~$4.3B, EMEA ~$5.0B, Enterprise Markets ~$4.3B in annual sales). Kenvue shareholders received $3.50 cash plus 0.14625 KMB shares per share, and KVUE ceased trading at market open. Management reiterates ~$2.1B run-rate synergies (~$1.9B cost synergies over three years plus ~$500M revenue-synergy profit, partially offset by ~$300M reinvestment within four years), though the filing carries no period-over-period financial results and flags integration, indebtedness and synergy-realization risks.

  • · Kenvue common stock (NYSE: KVUE) ceased trading as of market opening on November 2, 2026
  • · Three Kenvue directors joined the KMB board while Mae C. Jemison, Christa S. Quarles and Jaime A. Ramirez stepped down effective immediately
  • · Combined segment sales figures are FY2025 combined net sales recast for the proposed segment structure and are not Regulation S-X compliant pro forma information
  • · Filing flags risks including substantially increased indebtedness post-acquisition, ability to maintain credit ratings, integration costs exceeding expectations, and potential goodwill/intangible impairment
  • · KMB is a core S&P 500 component held by more than 400 ETFs and a Dividend Aristocrat with 54 consecutive years of dividend increases
CHURCH & DWIGHT CO INC /DE/ 4 neutral materiality 4/10

02-11-2026

President and CEO Dierker Richard A was awarded 40.334 Phantom Stock at $107.23 (~$4.33K).

  • · President and CEO Dierker Richard A was awarded 40.334 Phantom Stock at $107.23 (~$4.33K)
CHURCH & DWIGHT CO INC /DE/ 4 neutral materiality 4/10

02-11-2026

EVP Chief Tech&Global New Prod Linares Carlos G. was awarded 24.354 Phantom Stock at $107.23 (~$2.61K).

  • · EVP Chief Tech&Global New Prod Linares Carlos G. was awarded 24.354 Phantom Stock at $107.23 (~$2.61K)
CHURCH & DWIGHT CO INC /DE/ 4 neutral materiality 2/10

02-11-2026

EVP of Strategy, M&A, and BP Buchert Brian D was awarded 5.1 Phantom Stock at $107.23 (~$547).

  • · EVP of Strategy, M&A, and BP Buchert Brian D was awarded 5.1 Phantom Stock at $107.23 (~$547)

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 12 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →